APA (7th ed.) Citation

Ilyas, M., Singh, A., Gupta, P. P., Saad, T., Singh, P., Mishra, S., & Asati, A. (2025). Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples. Journal of Pharmacy & Bioallied Sciences, 17, S3057. https://doi.org/10.4103/jpbs.jpbs_1074_25

Chicago Style (17th ed.) Citation

Ilyas, Mohammad, Ajay Singh, Prasheelkumar Premnarayan Gupta, Talha Saad, Puja Singh, Satyendra Mishra, and Aashutosh Asati. "Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples." Journal of Pharmacy & Bioallied Sciences 17 (2025): S3057. https://doi.org/10.4103/jpbs.jpbs_1074_25.

MLA (9th ed.) Citation

Ilyas, Mohammad, et al. "Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples." Journal of Pharmacy & Bioallied Sciences, vol. 17, 2025, p. S3057, https://doi.org/10.4103/jpbs.jpbs_1074_25.